Robert Renninger, SVP, Finance and Accounting at Athira Pharma, Inc. (ATHA), sold 2,897 shares at $0.29 ($840) on 2025-07-01, disclosed to the SEC on 2025-07-02.
Open-market sale of $840 ATHA by SVP, Finance and Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATHA | SELL | 2025-01-03 | $2K | — | Filing → |